Medicine & Life Sciences

1. Non-Small Cell Lung Carcinoma 100%
2. polo-like kinase 1 88%
3. Lung Neoplasms 69%
4. biotinyl epidermal growth factor 62%
5. ErbB Receptors 55%
6. ((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide) 54%
7. Afatinib 44%
8. Single-Domain Antibodies 43%
9. Periplasm 38%
10. Erlotinib Hydrochloride 37%
11. Apoptosis 36%
12. Gefitinib 36%
13. Neoplasms 36%
14. rho-Associated Kinases 36%
15. Growth 35%
16. Mitogen-Activated Protein Kinase Kinases 31%
17. Mutation 29%
18. TNF-Related Apoptosis-Inducing Ligand Receptors 27%
19. Protein Kinases 26%
20. RNA Interference 25%
21. Protein Isoforms 23%
22. Carcinogenesis 22%
23. Escherichia coli 20%
24. Cell Line 19%
25. MAP Kinase Signaling System 19%
26. Cell Cycle Checkpoints 18%
27. Phenotype 17%
28. Cell Survival 16%
29. Protein-Tyrosine Kinases 14%
30. Health 14%
31. Streptavidin 13%
32. Oncogenes 13%
33. Pancreatic Neoplasms 13%
34. Therapeutics 13%
35. G2 Phase Cell Cycle Checkpoints 13%
36. Small Interfering RNA 13%
37. Pharmacology 12%
38. Psychological Inhibition 11%
39. STAT3 Transcription Factor 11%
40. Clinical Studies 10%
41. In Vitro Techniques 10%
42. Cell Culture Techniques 10%
43. Drug Combinations 10%
44. Actin Cytoskeleton 9%
45. Mitosis 9%
46. Down-Regulation 9%
47. Phosphorylation 9%
48. Cetuximab 8%
49. Biotin 8%
50. Cell Proliferation 7%